Results 141 to 150 of about 243,754 (245)

The role of TOMM20 in Mediating TERT translocation to mitochondria and its impact on mitophagy in membranous nephropathy

BMC Nephrology
Background In idiopathic membranous nephropathy (MN)—now a leading glomerular cause of end-stage kidney disease—mitochondrial quality control via mitophagy is increasingly recognized as a determinant of podocyte fate, yet the molecular switches governing
Limiao Yang, Hongle Yang, Mingming Zhang, Feifei Zhang, Xiaomei Liu, Zhiping Zhang, Jing Wang, Xiaolu Chen, Yuexuan Wang, Rui Zhang, Weihao Li   +10 more
doaj   +1 more source

Prevalence of enhanced granular expression of thrombospondin type-1 domain-containing 7A (THSD7A) and M-type phospholipase A2 receptor (PLA2R) in the glomeruli of patients with idiopathic membranous nephropathy (MN) and secondary MN.

, 2015
Prevalence of enhanced granular expression of thrombospondin type-1 domain-containing 7A (THSD7A) and M-type phospholipase A2 receptor (PLA2R) in the glomeruli of patients with idiopathic membranous nephropathy (MN) and secondary MN.
Hideo Yasuda (710367), Satoshi Baba (540358), Naro Ohashi (168272), Akihiko Kato (798462), Takamasa Iwakura (798461)   +4 more
core   +1 more source

The effects of traditional Chinese botanical medicine on membranous nephropathy

Frontiers in Pharmacology
Membranous nephropathy (MN), an autoimmune glomerulopathy driven by podocyte antigens, is a leading cause of end-stage renal disease (ESRD). However, its pathogenic mechanisms remain incompletely understood.
Tong Yin, Xinyu Zhang, Jiahao Liang, Xiaoming Yan, Zepeng Li, Wenlong Li, Jingyi Li, Lianhua Li, Ming Chen   +8 more
doaj   +1 more source

[Antiphospholipid antibodies in idiopathic membranous nephropathy].

Revista medica de Chile, 2005
1
Ardiles, L, Blackburn, E, Alruiz, P, Flores, C, Mezzano, S   +4 more
openaire   +3 more sources

A Multicenter Randomized Controlled Trial of Rituximab versus Cyclosporine in the Treatment of Idiopathic Membranous Nephropathy (MENTOR).

, 2015
BACKGROUND: Idiopathic membranous nephropathy remains the leading cause of nephrotic syndrome in Caucasian adults. Immunosuppressive therapy with cyclosporine (CSA) is often successful in reducing proteinuria, but its use is associated with a high ...
Brenchley, Paul; id_orcid, Greene, Eddie L, Reich, Heather N, Appel, Gerald B, Brenchley, Paul, Jefferson, J. Ashley, Juncos, Luis A, Jefferson, J Ashley, Gipson, Debbie S, Fervenza, Fernando C, Lieske, John C, Cattran, Daniel C, Blumenthal, Samuel S, Sussman, Amy N, Canetta, Pietro A, McCarthy, Ellen T, Leung, Nelson, Gipson, Patrick E, Barbour, Sean J, Hladunewich, Michelle A, Philibert, David, Hogan, Marie C, Kretzler, Matthias, Simon, James, Rizk, Dana V, Irazabal, Maria V, Sethi, Sanjeev, Sedor, John R, Mentor Consortium Grp, Radhakrishnan, Jai, Aslam, Nabeel, Green, Dollie F, Dillon, John J, Thomas, Leslie F, Rovin, Brad H, Hebert, Lee A, Eirin, Alfonso, Lasic, Lada B, Lafayette, Richard A   +38 more
core   +1 more source

Issue Information

Animal Models and Experimental Medicine, Volume 9, Issue 7, Page 1275-1276, July 2026.
wiley   +1 more source

The Mayo Clinic consensus report on membranous nephropathy; a promising step toward better treating the disease [PDF]

Membranous nephropathy is an immune complex disease caused by subepithelial deposits. The pathological manifestations of membranous nephropathy are considered by the creation of immune complexes in the epithelial cells of the glomerular basement membrane.
Mohammad Ali Esmaeil Pour, Azadeh Khayyat, Samaneh Zandifar, Leila Alem   +3 more
core   +2 more sources

Treatment of Idiopathic Membranous Nephropathy [PDF]

Nephron, 2008
openaire   +2 more sources

Supplementary Material for: A Multicenter Randomized Controlled Trial of Rituximab versus Cyclosporine in the Treatment of Idiopathic Membranous Nephropathy (MENTOR)

, 2017
Background: Idiopathic membranous nephropathy remains the leading cause of nephrotic syndrome in Caucasian adults. Immunosuppressive therapy with cyclosporine (CSA) is often successful in reducing proteinuria, but its use is associated with a high ...
Sethi S. (4153546), Hladunewich M.A. (4153534), Canetta P.A. (3629656), Gipson D.S. (4153543), Irazabal M.V. (4153540), Fervenza F.C. (4153531), Lafayette R.A. (4147267), Aslam N. (4142122), Barbour S.J. (4153537), Rovin B.H. (4153528)   +9 more
core   +1 more source

Idiopathic membranous nephropathy with focal segmental sclerosis

Терапевтический архив
Aim. To evaluate the clinical and pathological features and prognosis of idiopathic membranous nephropathy (IMN) with focal segmental sclerosis (FSGS) in a group of Russian patients. Materials and methods.
Elena S. Kamyshova, Irina N. Bobkova, Patimat А. Kakhsurueva, Amnat S. Abdulaeva, Tatiana Е. Rudenko, Ekaterina V. Stavrovskaya, Elena Yu. Andreeva, Olga А. Li, Aleksandr Yu. Suvorov   +8 more
doaj   +1 more source